1. Home
  2. GSBD vs OLMA Comparison

GSBD vs OLMA Comparison

Compare GSBD & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Goldman Sachs BDC Inc.

GSBD

Goldman Sachs BDC Inc.

N/A

Current Price

$7.69

Market Cap

943.9M

Sector

Finance

ML Signal

N/A

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

N/A

Current Price

$7.01

Market Cap

949.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GSBD
OLMA
Founded
2012
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
943.9M
949.3M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
GSBD
OLMA
Price
$7.69
$7.01
Analyst Decision
Sell
Strong Buy
Analyst Count
5
12
Target Price
$8.63
★ $35.50
AVG Volume (30 Days)
814.9K
★ 1.3M
Earning Date
11-05-2026
11-10-2026
Dividend Yield
★ 17.18%
N/A
EPS Growth
★ 87.27
15.00
EPS
★ 0.05
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$156.00
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.70
$6.24
52 Week High
$10.38
$36.26

Technical Indicators

Market Signals
Indicator
GSBD
OLMA
Relative Strength Index (RSI) 22.22 43.95
Support Level N/A $6.47
Resistance Level $9.08 $7.61
Average True Range (ATR) 0.22 0.60
MACD -0.08 0.02
Stochastic Oscillator 0.36 16.77

Price Performance

Historical Comparison
GSBD
OLMA

About GSBD Goldman Sachs BDC Inc.

Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests in U.S. middle-market companies such as banks and the public debt markets. The company focuses on the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Share on Social Networks: